Geriatric Medicine Through Medication-Use Complexity During Transitions Between Care Settings

Abstract

The complexity of medication use in older adults represents a significant challenge during transitions between care settings, such as hospital admissions, transfers to skilled nursing facilities, or discharge to home care. This review explores the multifaceted issues underlying medication-use complexity in geriatric medicine, focusing on epidemiology, pathophysiology, clinical features, diagnostic strategies, management, and recent advances. Emphasis is placed on evidence-based approaches for mitigating medication errors, optimizing pharmacotherapy, and improving transitional care outcomes for older adults.

Introduction

Transitions of care are critical junctures where older adults are highly susceptible to medication-related problems due to polypharmacy, altered pharmacokinetics, and communication breakdowns among healthcare teams. The prevalence of multimorbidity and age-related physiological changes necessitate a nuanced understanding of medication-use complexity to minimize adverse events and ensure continuity of care. This article synthesizes current scientific understanding and clinical recommendations to guide practitioners in managing medication regimens during care transitions in geriatric populations.

Epidemiology / Disease Burden

Globally, the geriatric population is expanding rapidly, with projections indicating that individuals aged 65 and older will constitute nearly 16% of the world’s population by 2050. Medication-related errors account for a substantial proportion of preventable adverse events during care transitions, with studies reporting error rates as high as 60% in older adults transferring between hospital and community settings. Polypharmacy, defined as the concurrent use of five or more medications, is prevalent in more than 50% of hospitalized older adults, increasing both morbidity and healthcare utilization. The cumulative burden of medication-use complexity leads to higher rates of rehospitalization, emergency department visits, and mortality.

Pathophysiology

Age-related changes in pharmacokinetics and pharmacodynamics significantly influence drug metabolism and response in geriatric patients. Reduced renal and hepatic function, altered body composition, and diminished homeostatic reserve affect drug absorption, distribution, metabolism, and excretion. Additionally, the presence of multiple chronic diseases often necessitates complex regimens, increasing the risk of drug-drug and drug-disease interactions. Cognitive and sensory impairments further complicate medication management, making older adults particularly vulnerable to errors during transitions.

Risk Factors

Major risk factors for medication-related complications during transitions include advanced age, polypharmacy, cognitive impairment, low health literacy, fragmented communication between providers, and inadequate medication reconciliation processes. Comorbidities such as chronic kidney disease, heart failure, and diabetes heighten susceptibility to pharmacological adverse effects. Social factors, including lack of caregiver support and limited access to pharmacy services, exacerbate the risk of medication mismanagement.

Clinical Features

Clinical manifestations of medication-use complexity range from subtle cognitive changes and functional decline to acute presentations such as delirium, falls, bleeding, and organ toxicity. Older adults may present atypically, with nonspecific symptoms that complicate identification of medication-related harm. Adverse drug reactions are frequently underrecognized, contributing to diagnostic uncertainty and suboptimal outcomes during care transitions.

Diagnosis

Effective diagnosis of medication-related issues during transitions relies on comprehensive medication reconciliation, involving systematic review and verification of all current medications, including over-the-counter and herbal products. Utilization of validated tools such as the Beers Criteria and STOPP/START criteria aids in identifying potentially inappropriate medications. Interdisciplinary collaboration incorporating pharmacists, geriatricians, and nursing staff is essential for accurate assessment and risk stratification.

Treatment & Management

Management strategies focus on individualized pharmacotherapy, deprescribing where appropriate, and ensuring clear communication across care settings. Implementation of standardized transition protocols, reconciliation checklists, and patient education interventions have demonstrated efficacy in reducing medication discrepancies. Regular review of medication regimens, assessment of adherence, and monitoring for adverse effects are essential components of ongoing management. Technological solutions such as electronic health records with integrated medication lists further support safe transitions for older adults.

Recent Advances / Emerging Therapies

Recent advances in geriatric pharmacotherapy include the development of clinical decision support systems that provide real-time alerts for potential drug interactions and dosing errors during transitions. Pharmacogenomic testing is emerging as a tool to personalize medication choices based on individual genetic profiles, potentially reducing adverse reactions. Additionally, telemedicine and remote monitoring technologies offer new modalities for post-discharge follow-up and medication management, improving communication and continuity of care.

Guideline Recommendations

Guidelines from professional societies such as the American Geriatrics Society and the Society of Hospital Medicine emphasize the importance of structured medication reconciliation, avoidance of high-risk drugs, and interprofessional collaboration during care transitions. Recommendations advocate for regular review of medication necessity, dose adjustment based on renal and hepatic function, and active involvement of patients and caregivers in decision-making. Evidence supports the adoption of standardized handoff tools and transition-of-care bundles to minimize errors and optimize outcomes.

Conclusion

Medication-use complexity remains a formidable challenge in geriatric medicine, particularly during transitions between care settings. A multidisciplinary, guideline-driven approach that prioritizes medication reconciliation, patient-centered care, and the integration of emerging technologies is essential to reduce adverse events and improve clinical outcomes. Ongoing research and innovation are needed to further refine strategies for safe, effective medication management in this vulnerable population.